Intrathecal pumps
- PMID: 18164490
- PMCID: PMC5084133
- DOI: 10.1016/j.nurt.2007.10.070
Intrathecal pumps
Abstract
Direct neuroaxis drug delivery has expanded the physician's armamentarium to provide treatment options to those who have failed more conservative interventions. Starting from Bier's 'cocainization of the spinal cord' in 1898, direct nervous system pharmacy delivery has long been recognized as an effective means to treat pain. Intrathecal pump systems are now commonplace in the management of numerous pain states, as well as of neuromuscular sequelae of central nervous system injury. There has been much advancement in the physiologic and pharmacologic understanding of direct neuromodulation, providing a growing number of treatment options depending on the specific disease state. As well, surgical techniques and catheter systems have undergone refinements providing improved long-term safety and efficacy. We present a review of the historical evolution to current intrathecal therapies, as well as a dialog regarding patient selection, drug options, and side effects. Also, included is a discussion of surgical techniques, current delivery options and complications concerning pump placement.
Similar articles
-
Intrathecal analgesia.Anesthesiol Clin. 2007 Dec;25(4):863-82, viii. doi: 10.1016/j.anclin.2007.07.001. Anesthesiol Clin. 2007. PMID: 18054150 Review.
-
Long-Term Intrathecal Analgesia With a Wireless Analgesia Pump System in the Home Care of Patients With Advanced Cancer.Am J Hosp Palliat Care. 2017 Mar;34(2):148-153. doi: 10.1177/1049909115615110. Epub 2016 Jul 11. Am J Hosp Palliat Care. 2017. PMID: 26537661
-
Polyanalgesic Consensus Conference--2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain.Neuromodulation. 2012 Sep-Oct;15(5):467-82; discussion 482. doi: 10.1111/j.1525-1403.2012.00486.x. Epub 2012 Jul 31. Neuromodulation. 2012. PMID: 22849581
-
The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks.Neuromodulation. 2017 Feb;20(2):155-176. doi: 10.1111/ner.12579. Epub 2017 Jan 2. Neuromodulation. 2017. PMID: 28042914 Review.
-
Intrathecal Drug Delivery Systems for Cancer Pain: An Analysis of a Prospective, Multicenter Product Surveillance Registry.Anesth Analg. 2020 Feb;130(2):289-297. doi: 10.1213/ANE.0000000000004425. Anesth Analg. 2020. PMID: 31567325 Free PMC article. Clinical Trial.
Cited by
-
History and present state of targeted intrathecal drug delivery.Curr Pain Headache Rep. 2015;19(2):474. doi: 10.1007/s11916-014-0474-8. Curr Pain Headache Rep. 2015. PMID: 25638694 Review.
-
Regenerative therapies for central nervous system diseases: a biomaterials approach.Neuropsychopharmacology. 2014 Jan;39(1):169-88. doi: 10.1038/npp.2013.237. Epub 2013 Sep 4. Neuropsychopharmacology. 2014. PMID: 24002187 Free PMC article. Review.
-
Non-Viral Nucleic Acid Delivery Strategies to the Central Nervous System.Front Mol Neurosci. 2016 Nov 1;9:108. doi: 10.3389/fnmol.2016.00108. eCollection 2016. Front Mol Neurosci. 2016. PMID: 27847462 Free PMC article. Review.
-
Implantable system for chronotherapy.Sci Adv. 2021 Nov 26;7(48):eabj4624. doi: 10.1126/sciadv.abj4624. Epub 2021 Nov 26. Sci Adv. 2021. PMID: 34826238 Free PMC article.
-
Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient.Front Pain Res (Lausanne). 2022 Jun 16;3:900566. doi: 10.3389/fpain.2022.900566. eCollection 2022. Front Pain Res (Lausanne). 2022. PMID: 35782225 Free PMC article. Review.
References
-
- Rico RC, Hobika GH, Avellanosa AM, Trudnowski RJ, Rempel J, West CR. Use of intrathecal and epidural morphine for pain relief in patients with malignant diseases: a preliminary report. J Med. 1982;13:223–231. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials